FDA Warns Italian Device Facility of CGMP Violations
The Food and Drug Administration warned Italian device manufacturer Spes Medica Srl that its Battipaglia, Italy, facility isn’t conforming to current good manufacturing practice requirements. Requests for premarket approvals and government certificates related to the violative devices, electromyography needles, may…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
be denied unless the violations are corrected, FDA said.